MLEC
Moolec Science S.A.NASDAQHealthcare$6.95+64.60%ClosedMarket Cap: $5.0M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-0.07
P/S
0.02
EV/EBITDA
-3.69
DCF Value
$3,195.75
FCF Yield
-362.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
34.2%
Operating Margin
-3.1%
Net Margin
-33.4%
ROE
376.8%
ROA
-54.4%
ROIC
-5.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| FY 2024 | $333.6M | $-111.5M | $-258.75 |
| Q2 2024 | $2.6M | $-2.4M | $-0.90 |
| Q1 2024 | $1.6M | $-1.9M | $-0.75 |
| Q4 2023 | $1.5M | $-2.5M | $-1.05 |
Trading Activity
Insider Trades
View AllFalottico Valeria Inesofficer: Chief Financial Officer
SellThu Mar 19
Falottico Valeria Inesofficer: Chief Financial Officer
SellThu Mar 19
Falottico Valeria Inesofficer: Chief Financial Officer
SellThu Mar 19
Varela Lorenzo Romualdo Marianodirector
SellWed Mar 18
Diaz Dellavalle Paola Alexandraofficer: Chief Technology Officer
SellWed Mar 18
Company Info
Sector
Healthcare
Industry
—
Country
LU
Exchange
NASDAQ
Beta
-0.66
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.